With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)Read More
Kaléo is a new type of pharmaceutical company, dedicated to building innovative solutions for serious and life-threatening medical conditions.
By listening and truly seeking to understand your input, we are creating a brand new dynamic in our industry – patient-inspired design through partnerships that give you direct input into developing a new generation of solutions that better address your needs. We recognize that you are the expert on your own medical condition.What We Believe
Human Factors Engineering (HFE) has been central to kaléo’s collaborative approach from our founding. This is the process by which we have patients and caregivers tell us what they need, and then we incorporate these inputs into product design. Kaléo is recognized nationally and internationally for our expertise in this field. It is kaléo’s hope that HFE becomes more common in the pharmaceutical industry so that receiving your medicines correctly becomes less of a concern for patients. Our process of collaborating with patients ensures that the final product has been evaluated through your (i.e. the patient’s) eyes.